Does a Clinical Support System for Parenteral Nutrition (PN) Facilitate the Judgement on Choosing the Most Effective Commercial Solution Per Patient (and Modify it, if Necessary)?
CDSS
1 other identifier
interventional
67
1 country
1
Brief Summary
Standard formulas of PN have been developed and provided to patients. Only few randomized controlled studies compared standardized vs individualized PN. Individually tailored PN, only if standard PN solutions do not meet patient's nutritional needs. ASPEN society recommends the use computerized prescribing. Technology has enabled the incorporation of medical guidelines in CDSSs. New approach: Comparison of patient's calculated nutritional needs with commercial available solutions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 18, 2022
CompletedFirst Submitted
Initial submission to the registry
November 17, 2022
CompletedFirst Posted
Study publicly available on registry
January 4, 2023
CompletedJanuary 4, 2023
December 1, 2022
1 year
November 17, 2022
December 30, 2022
Conditions
Outcome Measures
Primary Outcomes (6)
Estimate of Macro and Micro Nutrient Needs for PN.
Estimation of macro and micro nutrient needs for PN by CDSS: amino acids, carbohydrates, lipid, electrolytes, energy and fluids.
0 months - 12 months
Estimate the difference between actual PN energy needs (kcal per day) and energy provided in the PN solutions available in the market (kcal per 100ml).
Compare Ready to Use PN solutions with patient's actual nutritional energy needs in order to customize PN for optimum nutrition outcome.
0 months - 12 months
Estimate the difference between actual PN needs and nutrient content of Ready to use Solution for PN available in the market.
Compare Ready to Use PN solutions on total grams of amino acids with patient's actual nutritional needs on total grams of amino acids in order to optimize patient's PN for better nutritional outcome.
0 months - 12 months
Estimate the difference between actual PN needs and nutrient content of Ready to use Solution for PN available in the market.
Compare Ready to Use PN solutions on total grams of fat with patient's actual nutritional needs on total grams of fat in order to optimize patient's PN for better nutritional outcome.
0 months - 12 months
Estimate the difference between actual PN needs and nutrient content of Ready to use Solution for PN available in the market.
Compare Ready to Use PN solutions on total grams of carbohydrates with patient's actual nutritional needs on total grams of carbohydrates in order to optimize patient's PN for better nutritional outcome.
0 months - 12 months
Difference of time spent on estimation of PN needs when conducted by hand and CDSS.
Compare time spent for a) calculation of nutritional needs, b) prescription and c) transcription by using CDSS or made by hand.
0 months - 12 months
Study Arms (2)
Dispense Ready to Use PN Solutions
OTHERDispensed to patient commercial solution.
Dispense the most effective commercial Solution calculated with the use of the CDSS
OTHERDispensed to patient the most effective commercial solution after the CDSS calculations.
Interventions
The use of Clinical Decision Support System in Parenteral Nutrition
Eligibility Criteria
You may qualify if:
- Hospitalize Patients unable to be fed via gastrointestinal tract.
- Hemodynamically stable patients.
- PN regimen should remain the same for the first 3 days.
You may not qualify if:
- Hemodynamically unstable.
- Anticipated need for parenteral nutrition less than 5 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Iaso General Hospital
Athens, Greece
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Parenteral Nutrition unit, PharmD
Study Record Dates
First Submitted
November 17, 2022
First Posted
January 4, 2023
Study Start
February 12, 2021
Primary Completion
February 15, 2022
Study Completion
September 18, 2022
Last Updated
January 4, 2023
Record last verified: 2022-12